Inflammatory bowel disease: sorting out the treatment options.
An increasing array of treatments such as immunosuppressive drugs and tumor necrosis factor inhibitors can offer patients with ulcerative colitis and Crohn disease improved relief from symptoms with fewer adverse effects. Several additional drugs have shown promise, including nicotine, antimicrobials, and heparin.
Department of Gastroenterology, The Cleveland Clinic Foundation, Ohio 44195, USA.
Jason M
JM
Wolf
Bret A
BA
Lashner
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005395:Fish Oils / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D005395:Fish Oils; D007166:Immunosuppressive Agents; D013256:Steroids; D012460:Sulfasalazine; D016572:Cyclosporine; D001379:Azathioprine; D008727:Methotrexate